Procurement Summary
Country: Brazil
Summary: Acquisition of Standardized Medicines Belonging to Groups: 09.C.02.K - other Antihypertensive, 09.C.10.A - Lipid Modifying Agents, Isolated, 09.C.01.D - Vasodilators Used in do ...
Deadline: 11 Aug 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 123646767
Document Ref. No.: 90155/2025
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of standardized drugs belonging to groups: 09.C.02.K - Other antihypertensive, 09.C.10.A - Lipid modifying agents, isolated, 09.C.01.D - Vasodilators used in heart disease, 09.C.07.A - Beta Blockers, 09.D.04.A - Anti -ruriginous, including antihistamines, anesthetic, etc., 09.H.05.B - Antiparatyroidagers, 09.H.01.B - Pituitary posterior lob hormones, 09.H.02.A - Corticosteroids of systemic use
UASG Code: 926119
Notice from: 07/30/2025 from 08:00 to 12:00 and from 13:00 at 17:59 hs
Proposal Delivery: From 07/30/2025 to 08:00
Ambrisentana, 10 mg concentration
Quantity: 10530
Quantity: 3510
Ambrisentana, 5 mg concentration
Quantity: 21060
Quantity: 7020
Bosentana, dosage 62.5 MG
Quantity: 71400
Genfibrozila, dosage 600 mg
Quantity: 4805
Isosorbida, active ingredient salt mononitrate, dosage 40 mg
Quantity: 73080
Propranolol Hydrochloride, dosage 40 mg
Quantity: 3702367
Lidocaine hydrochloride, dosage 2%, presentation jelly
Quantity: 96190
Lidocaine hydrochloride, Dosage 2%, presentation jelly
Quantity: 32063
Synthetic calcitonin, salmon composition, 200 IU/dose concentration, pharmaceutical form nasal spray
Quantity: 164
Acetate disappointment, dosage 0.1 mg/ml, presentation nasal solution
Quantity: 86
Methylprednisolone, active ingredient salt acetate, Dosage 40 mg/ml, pharmaceutical form injectable suspension
Quantity: 1172
Dimenidrinate, presentation associated with pyridoxin + glucose + fructose, 3mg + 5mg + 100mg/100mg/ml, injectable solution
Quantity: 50028
Dimenhydrinate, presentation associated with pyridoxin + glucose + Fructose, 3mg + 5mg + 100mg + 100mg/ml, type solution ...
Documents
Tender Notice